Big Move For Equillium, Inc.

Wed 11 Nov 20 at 05:30 PM
Big Move For Equillium, Inc.

Equillium, Inc. (EQ:NASDAQ) jumped higher at $5.04, representing a gain of 44.8%. On Tue 10 Nov 20, EQ:NASDAQ hit a New 2-Week Low of $3.48. The stock got featured on our News Catalysts scanner on Tue 10 Nov 20 at 07:34 PM in the 'EARNINGS' category. From Tue 27 Oct 20, the stock recorded 20.00% Up Days and 18.18% Green Days

The stock spiked on Fri 30 Oct 20 at $7.51 with a volume of 17M+.

About Equillium, Inc. (EQ:NASDAQ)

Equillium Inc is a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, which is a clinical stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus and multiple sclerosis.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.